OneTouch Ultra Plus Control Solution
Ref 023810, 024065
OneTouch Ultra Plus Control Solution (023810) is an in vitro diagnostic device (EU IVDD Annex II List B; EMDN category diabetes controls) made by Lifescan Europe, registered in EUDAMED on 25 May 2022 (Basic UDI-DI B-07613427007014), active as of 7 Nov 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not applicable
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD | NumberB-07613427007014 | Date25 May 2022 | StatusActive |
Official records
- EUDAMED public site B-07613427007014
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDD Active
Specification
- Model / reference
- 023810, 024065
- Primary DI / UDI-DI
- 07613427007014, 07613427004983
- Basic UDI-DI
- B-07613427007014, B-07613427004983
- EMDN code
- W0101050205 Diabetes controls
- Device class
- Class IVD Annex II List B
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Belgium
Manufacturer details
- EUDAMED SRN
- CH-MF-000014224
- Authorised representative
- LifeScan Deutschland GmbH DE-AR-000005105
Similar devices in this category
Other devices filed under DIABETES CONTROLS.
- Multichem A1c HB001A by Techno-Path Manufacturing
- BioHermes Glycohemoglobin Quality Control A1C-GE C01 A1C-C12 by Wuxi Biohermes Bio & Medical Technology Co., Ltd.
- extendSURE™ HbA1c Liquid Controls B12397 by Canterbury Scientific, Ltd.
- HbA1c, Frozen Whole Blood HBAFr-03.1 by Streekziekenhuis Koningin Beatrix
- HbA1c, lyophilised hemolysate Level High HBA-04.3 by Streekziekenhuis Koningin Beatrix
- Diazyme DZ168A-CON by Diazyme Laboratories, Inc.
- extendSURETM Haemoglobin A1c Lyophilised Controls HB710SBAr by Canterbury Scientific, Ltd.
- HbA1c Control Material 0320200302 by Shenzhen Lifotronic Technology Co., Ltd.
- Multichem A1c HB000A by Techno-Path Manufacturing
- NOVA Lite® IFA Pancreatic Islet Cell Positive Control 704005 by Inova Diagnostics. Inc.